Home » About ETC » Project Review Committee
Project Review Committee

We draw on the leadership, knowledge and expertise of our advisors who are seasoned industry executives, eminent scientists and healthcare veterans with decades of experience in leading edge science and biopharmaceutical R&D operations and commercialization.


Tadataka Yamada

Executive Vice-President and
Board Member, Takeda Pharmaceuticals and Senior
Executive in Residence, Frazier Healthcare


Sir David Lane
A*STAR Chief Scientist; Founder
and former CEO of ETC

Roger Ulrich
Biotech Executive & Entrepreneur

Frank Bennett
Senior VP, Research,
Isis Pharmaceuticals


Benjamin Seet
Deputy Executive Director, A*STAR Biomedical Research Council

Peter Goodfellow
Professor, University of Kent &
Science Advisor, Abingworth Bioventures
Stan Kaye

Stan Kaye
Professor of Medical Oncology
Head of Division of
Cancer Therapeutics,
Head of Division of Clinical Studies,
Cancer Research UK

Stephen Frye
Fred Eshelman Distinguished Professor,
Director Center for Integrative Chemical Biology and Drug Discovery,
Division of Chemical Biology and Medicinal Chemistry,
UNC Eshelman School of Pharmacy